YTHDF2 is also highly expressed in multiple myeloma (MM), where it promotes proliferation through m6A-dependent degradation of EGR1 mRNA, thereby disrupting the EGR1/p21cip1/waf1/CDK2–Cyclin E1 axis. Here, CDKN1A is linked to Miyoshi myopathy.